Weiss Multi-Strategy Advisers LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$4,498,000
+181.5%
66,052
+32.1%
0.12%
+147.9%
Q2 2022$1,598,000
+476.9%
50,000
+525.0%
0.05%
+700.0%
Q1 2022$277,000
-62.8%
8,000
-68.5%
0.01%
-64.7%
Q4 2021$744,000
+14.5%
25,414
-0.4%
0.02%
+21.4%
Q3 2021$650,000
-15.6%
25,518
+16.0%
0.01%
-17.6%
Q2 2021$770,000
+17.6%
22,000
+36.9%
0.02%
+21.4%
Q1 2021$655,000
-30.2%
16,073
-25.8%
0.01%
-22.2%
Q4 2020$938,000
-46.8%
21,666
-32.3%
0.02%
-61.7%
Q3 2020$1,764,000
+3.0%
32,000
+17.9%
0.05%
-4.1%
Q2 2020$1,713,000
+26.9%
27,134
+2.7%
0.05%
-7.5%
Q1 2020$1,350,000
+13.3%
26,416
+76.1%
0.05%
+178.9%
Q4 2019$1,192,000
+63.7%
15,0000.0%0.02%
+26.7%
Q3 2019$728,000
-7.7%
15,0000.0%0.02%
-28.6%
Q2 2019$789,000
+74.6%
15,000
+50.0%
0.02%
+90.9%
Q2 2018$452,000
-50.1%
10,000
-46.7%
0.01%
-62.1%
Q1 2018$906,000
+129.9%
18,750
+87.5%
0.03%
+190.0%
Q4 2017$394,00010,0000.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders